相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NANT cancer vaccine an orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T cell therapy in patients with third line or greater metastatic pancreatic cancer.
Tara Elisabeth Seery et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells
Jay Friedman et al.
ORAL ONCOLOGY (2019)
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
Fernando Souza-Fonseca-Guimaraes et al.
TRENDS IN IMMUNOLOGY (2019)
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK
Amber J. Giles et al.
JCI INSIGHT (2019)
NKG2D: A Master Regulator of Immune Cell Responsiveness
Felix M. Wensveen et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Neutrophil's Choice: Phagocytose vs Make Neutrophil Extracellular Traps
Angelo A. Manfredi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies
Jay Friedman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
Kathleen E. Fenerty et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
Cheng Sun et al.
ONCOIMMUNOLOGY (2017)
ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody
Caroline Jochems et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Sourav Paul et al.
FRONTIERS IN IMMUNOLOGY (2017)
ImageJ2: ImageJ for the next generation of scientific image data
Curtis T. Rueden et al.
BMC BIOINFORMATICS (2017)
The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer
Sylvain Ladoire et al.
AUTOPHAGY (2016)
STAT3 regulates hypoxia-induced epithelial mesenchymal transition in oesophageal squamous cell cancer
Yao Cui et al.
ONCOLOGY REPORTS (2016)
Intratumoral oxygen gradients mediate sarcoma cell invasion
Daniel M. Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
Caroline Jochems et al.
ONCOTARGET (2016)
Regulation of Natural Killer Cell Function by STAT3
Nicholas A. Cacalano
FRONTIERS IN IMMUNOLOGY (2016)
Ghrelin Inhibits the Differentiation of T Helper 17 Cells through mTOR/STAT3 Signaling Pathway
Yanhui Xu et al.
PLOS ONE (2015)
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
Christine Pasero et al.
ONCOTARGET (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
Joseph C. Walsh et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
Dagmar Gotthardt et al.
BLOOD (2014)
Perforin: an important player in immune response
Iwona Osinska et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells
M. R. Pawlus et al.
ONCOGENE (2014)
LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity
Konrad Krzewski et al.
BLOOD (2013)
Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage
Andre Cohnen et al.
BLOOD (2013)
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Application of Selected Reaction Monitoring for Multiplex Quantification of Clinically Validated Biomarkers in Formalin-Fixed, Paraffin-Embedded Tumor Tissue
Todd Hembrough et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
Subhashis Sarkar et al.
PLOS ONE (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Human NKG23-ligands: cell biology strategies to ensure immune recognition
Lola Fernandez-Messina et al.
FRONTIERS IN IMMUNOLOGY (2012)
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Sophia Platonova et al.
CANCER RESEARCH (2011)
Hypoxia in prostate cancer: A powerful shield against tumour destruction?
L. Marignol et al.
CANCER TREATMENT REVIEWS (2008)
STAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination
Joo Eun Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2008)
Serial Killing of Tumor Cells by Human Natural Killer Cells - Enhancement by Therapeutic Antibodies
Rauf Bhat et al.
PLOS ONE (2007)
Activation of NK cell cytotoxicity
MJ Smyth et al.
MOLECULAR IMMUNOLOGY (2005)
CD107a as a functional marker for the identification of natural killer cell activity
G Alter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Natural killer cell-mediated basal and interferon-enhanced cytotoxicity against liver cancer cells is significantly impaired under in vivo oxygen conditions
T Fink et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
MHC class I antigens, immune surveillance, and tumor immune escape
A Garcia-Lora et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
The ABCs of granule-mediated cytotoxicity: New weapons in the arsenal
J Lieberman
NATURE REVIEWS IMMUNOLOGY (2003)
Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
Activation of natural killer cells with interleukin 2 (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells
C Lehmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGFβ is reversed by IL-15
JDM Campbell et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
